ArticleCancers2023

Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells.

Terutsugu Koya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.